MarketCapTrends
PBYI

Puma Biotechnology Inc. (PBYI)

NASDAQ · Healthcare

Puma Biotechnology Inc. annual/quarterly long term debt history from 2017 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.

  • Puma Biotechnology Inc. long term debt for the quarter ending December 31, 2025 were 22.7M, a 66.66% decrease year-over-year.
  • Puma Biotechnology Inc. long term debt for 2025 were 22.7M, a 66.66% decrease from 2024.
  • Puma Biotechnology Inc. long term debt for 2024 were 68.0M, a 33.33% decrease from 2023.
  • Puma Biotechnology Inc. long term debt for 2023 were 102.0M, a 0.00% increase from 2022.
  • Puma Biotechnology Inc. long term debt for 2022 were 102.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Puma Biotechnology Inc. Annual Long Term Debt (Millions of US $)
2025$23
2024$68
2023$102
2022$102
2021$102
2020$84
2019$95
2018$152
2017$48
Puma Biotechnology Inc. Quarterly Long Term Debt (Millions of US $)
2025-12-31$23
2024-12-31$68
2023-12-31$102
2022-12-31$102
2021-12-31$102
2020-12-31$84
2019-12-31$95
2018-12-31$152
2017-12-31$48

Puma Biotechnology Inc. Long Term Debt — FAQ

Puma Biotechnology Inc. (PBYI) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see PBYI's long term debt history?

The chart and table above show Puma Biotechnology Inc.'s long term debt by year and by quarter, including the growth rate.